39,369 Shares in Verona Pharma plc (NASDAQ:VRNA) Acquired by Point72 Europe London LLP
MarketBeat
Point72 Europe London LLP bought a new position in Verona Pharma plc (NASDAQ:VRNA - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 39,369 shares of the company's stock, valued at approximately $1,828,000.
NASDAQ:VRNA